Work

Combining mertk inhibitor mrx-2843 with venetoclax and 5-azacitidine in AML

Year: 2025

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2025-6795

Authors: Aashis Thapa, Edward Henderson, Austre Y. Schiaffino Bustamante, Gianna Branella, Sunil Raikar, Xiaodong Wang, Stephen V. Frye, H. Shelton Earp, Deborah DeRyckere, Douglas K. Graham

Institutions: Emory University, Children's Healthcare of Atlanta, University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7108671718

Cites:

Cited by:

Related to: